chr9-33166911-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001497.4(B4GALT1):c.259C>T(p.Pro87Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,576,632 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001497.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B4GALT1 | NM_001497.4 | c.259C>T | p.Pro87Ser | missense_variant | 1/6 | ENST00000379731.5 | NP_001488.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B4GALT1 | ENST00000379731.5 | c.259C>T | p.Pro87Ser | missense_variant | 1/6 | 1 | NM_001497.4 | ENSP00000369055.4 | ||
B4GALT1 | ENST00000535206.5 | c.259C>T | p.Pro87Ser | missense_variant | 1/3 | 1 | ENSP00000440341.1 | |||
B4GALT1-AS1 | ENST00000654325.1 | n.-37G>A | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00158 AC: 240AN: 152234Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000284 AC: 53AN: 186338Hom.: 0 AF XY: 0.000233 AC XY: 24AN XY: 103072
GnomAD4 exome AF: 0.000178 AC: 254AN: 1424282Hom.: 0 Cov.: 31 AF XY: 0.000177 AC XY: 125AN XY: 706454
GnomAD4 genome AF: 0.00158 AC: 241AN: 152350Hom.: 1 Cov.: 33 AF XY: 0.00152 AC XY: 113AN XY: 74498
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 06, 2023 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 07, 2023 | Variant summary: B4GALT1 c.259C>T (p.Pro87Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 186338 control chromosomes, with increased frequency in populations of African descent (0.0044 in 10762 control chromosomes). To our knowledge, no occurrence of c.259C>T in individuals affected with B4GALT1-CDG and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
B4GALT1-congenital disorder of glycosylation Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 08, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at